Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v4-FR
Language French French
Date Updated 2020-02-13 2017-03-14
Drug Identification Number 02319411 02319411
Brand name TEVA-HYDROMORPHONE TEVA-HYDROMORPHONE
Common or Proper name HYDROMORPHONE HYDROCHLORIDE HYDROMORPHONE HYDROCHLORIDE
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients HYDROMORPHONE HYDROCHLORIDE HYDROMORPHONE HYDROCHLORIDE
Strength(s) 2MG 2MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 100 100
ATC code N02AA N02AA
ATC description OPIOIDS OPIOIDS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2014-11-05 2014-11-05
Estimated end date Unknown
Actual end date 2018-08-31
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments Product Discontinued.
Health Canada comments